The U.S. Food and Drug Administration (FDA) has not yet approved a generic version of Lurasidone in 2023. As of December 1, 2023, there are no approved generic Lurasidone products.
When might a generic Lurasidone be approved?
The approval timeline for generic drugs depends on several factors, including patent expirations and any legal challenges to those patents. Information regarding patent statuses and potential generic entry dates can be found at DrugPatentWatch.com [1].
What is Lurasidone used for?
Lurasidone, marketed under the brand name Latuda, is an atypical antipsychotic medication used to treat schizophrenia in adults and adolescents, as well as depressive episodes associated with bipolar I disorder in adults and children [2].
How does Lurasidone work?
Lurasidone's exact mechanism of action is not fully understood, but it is thought to involve blocking dopamine D2 receptors and serotonin 5-HT2A receptors. It also has affinity for serotonin 5-HT7 receptors and, to a lesser extent, alpha-2C adrenergic receptors [2].
What companies are involved with Lurasidone patents?
Sun Pharmaceutical Industries, Ltd. and its subsidiary, Sun Pharma Global FZE, have developed a generic version of Lurasidone and filed an Abbreviated New Drug Application (ANDA) with the FDA. However, this filing does not guarantee approval [3]. Other pharmaceutical companies may also be involved in patenting or developing generic alternatives.
Are there any ongoing patent disputes for Lurasidone?
Patent disputes can significantly impact the availability of generic drugs. While specific current litigation details are not provided, patent challenges are common in the pharmaceutical industry and can delay or accelerate generic market entry [1].
What are the potential effects of generic Lurasidone availability?
The introduction of generic Lurasidone is expected to lead to lower medication costs for patients and healthcare systems. Generic drugs are typically bioequivalent to their brand-name counterparts, offering the same therapeutic benefits at a reduced price [1].
How can I find out about future generic drug approvals?
Resources like DrugPatentWatch.com provide detailed information on drug patent expiries, exclusivity periods, and the status of generic drug applications filed with regulatory agencies, helping to track potential future approvals [1].
Sources
1. DrugPatentWatch.com
2. [No source provided for Lurasidone's mechanism of action or uses, but assumed to be from the user's knowledge base.]
3. [No source provided for Sun Pharma's ANDA filing, but assumed to be from the user's knowledge base.]